(2,4-Dimethyl-1,3-thiazol-5-yl)methylamine dihydrochloride | 1185293-90-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (2,4-Dimethyl-1,3-thiazol-5-yl)methylamine dihydrochloride
• 英文别名: (2,4-dimethyl-1,3-thiazol-5-yl)methanamine;dihydrochloride
• CAS: 1185293-90-6
• 化学式: C6H12Cl2N2S
• 分子量: 215.14
• InChiKey: BAXJSYXKOHKTBE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.06
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  67.2
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• Pharmaceutical waste disposal assembly
  申请人：Stryker Corporation

  公开号：US10086416B2

  公开（公告）日：2018-10-02

  A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a receiver body (19) and a first reaction agent (287). The receiver body (19) is configured to receive the pharmaceutical waste. The receiver body (19) includes a body interior wall (921A) that defines a body interior (921B). The first reaction agent (287) is positioned within the body interior (921B) so that the first reaction agent (287) contacts the body interior wall (921A) prior to receiving the pharmaceutical waste. The first reaction agent (287) chemically reacts with the pharmaceutical waste so that the pharmaceutical waste is rendered unrecoverable. The first reaction agent (287) can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent (287) can include activated charcoal.

  用于处置未加工药物废物的药物废物处置组件 (10) 包括一个接收体 (19) 和一个第一反应剂 (287)。接收器主体（19）被配置为接收医药废物。接收器主体 (19) 包括限定主体内部 (921B) 的主体内壁 (921A)。第一反应剂 (287) 位于主体内部 (921B) 中，以便第一反应剂 (287) 在接收药物废料之前接触主体内壁 (921A)。第一反应剂 (287) 与药物废物发生化学反应，使药物废物无法回收。第一反应剂 (287) 可以包括变性剂和阻遏剂中的至少一种。此外，第一反应剂（287）还可以包括活性炭。
• Waste disposal system and waste receiver for receiving and disposing of pharmaceutical waste material
  申请人：Stryker Corporation

  公开号：US10940513B2

  公开（公告）日：2021-03-09

  A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

  一种废物处理系统，带有一个用于接收药物废料的废物接收器。一个锁定组件固定在一个固定表面上，并从锁定配置驱动到解锁配置。锁定组件的锁芯可从废物接收器的接收器主体的前壁向前延伸，以便在锁定配置中与盖子的锁定功能相啮合。盖子固定特征可防止盖子与接收器本体的轴向脱钩。移动啮合特征，使其与接收器本体脱离，接收器本体远离固定表面，使锁定组件与盖子脱离。盖子与盖子固定特征脱钩，并与接收器本体耦合，以密封药物废料。锁定组件可从锁定通道中取出，以便对废物接收器进行处置。
• METHOD OF DISPOSING OF WASTE RECEIVER, WASTE RECEIVER FOR PHARMACEUTICAL WASTE AND METHOD OF ASSEMBLING THE WASTE RECEIVER
  申请人：Stryker Corporation

  公开号：EP3902638A1

  公开（公告）日：2021-11-03
• PHARMACEUTICAL WASTE DISPOSAL ASSEMBLY
  申请人：Maness David A.

  公开号：US20120305132A1

  公开（公告）日：2012-12-06

  A pharmaceutical waste disposal assembly ( 10 ) for disposing of raw pharmaceutical waste comprises a first receiver body ( 19 ) and a first reaction agent ( 287 ). The first receiver body ( 19 ) receives the pharmaceutical waste. The first receiver body ( 19 ) includes a receiver bottom ( 283 ). The first reaction agent ( 287 ) is positioned within the first receiver body ( 19 ) and spaced apart from the receiver bottom ( 283 ). The pharmaceutical waste reacts with the first reaction agent ( 287 ) to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body ( 19 ) can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent ( 287 ) may include one or more of a denaturant, an emetic and a tittering agent. For example, the first reaction agent ( 287 ) may include one or more of quinine, ipecac and denatonium benzoate.
• Pharmaceutical Waste Disposal Assembly
  申请人：Stryker Corporation

  公开号：US20190084018A1

  公开（公告）日：2019-03-21

  A pharmaceutical waste disposal assembly ( 10 ) for disposing of raw pharmaceutical waste includes a first receiver body and a second receiver body. The assembly further includes a first reaction agent and a second reaction agent. The first reaction agent and the second reaction agent renders the pharmaceutical waste unrecoverable. The first reaction agent can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent can include activated charcoal.